Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PLAGL1
|
ENSG00000118495.14 | PLAG1 like zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PLAGL1 | hg19_v2_chr6_-_144385698_144385742 | 0.18 | 3.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_51472031 | 7.80 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr19_-_51504852 | 6.53 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
chr18_+_33877654 | 6.13 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
chr19_-_51472222 | 5.88 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
chr2_-_241396131 | 5.82 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
chr19_-_55658687 | 5.77 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr22_+_38071615 | 5.50 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
chr19_+_35645817 | 5.29 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr13_-_20806440 | 5.16 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
chr2_-_1748214 | 5.07 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr8_+_22022800 | 5.02 |
ENST00000397814.3
|
BMP1
|
bone morphogenetic protein 1 |
chr19_-_51014460 | 4.95 |
ENST00000595669.1
|
JOSD2
|
Josephin domain containing 2 |
chr17_-_76899275 | 4.85 |
ENST00000322630.2
ENST00000586713.1 |
DDC8
|
Protein DDC8 homolog |
chr1_-_17307173 | 4.82 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
chr4_-_103266355 | 4.81 |
ENST00000424970.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr1_-_20812690 | 4.81 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr19_-_51014345 | 4.67 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
chr19_-_19051103 | 4.52 |
ENST00000542541.2
ENST00000433218.2 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr9_+_131182697 | 4.47 |
ENST00000372838.4
ENST00000411852.1 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
chr19_-_55658281 | 4.45 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr4_+_4388805 | 4.30 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
chr19_-_1513188 | 4.26 |
ENST00000330475.4
|
ADAMTSL5
|
ADAMTS-like 5 |
chr19_-_51471381 | 4.18 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr8_-_23261589 | 4.15 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
chr9_+_128509663 | 4.14 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr13_+_110959598 | 4.07 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr22_+_31489344 | 4.05 |
ENST00000404574.1
|
SMTN
|
smoothelin |
chr19_-_19051993 | 3.89 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr19_-_51487071 | 3.80 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
chr1_-_205419053 | 3.78 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
chr1_+_32042131 | 3.78 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr22_-_37640456 | 3.72 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr10_-_75634219 | 3.71 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr11_-_2906979 | 3.70 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr16_-_56459354 | 3.69 |
ENST00000290649.5
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase |
chr9_-_136344197 | 3.67 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr19_+_2249308 | 3.66 |
ENST00000592877.1
ENST00000221496.4 |
AMH
|
anti-Mullerian hormone |
chr11_+_69924639 | 3.64 |
ENST00000538023.1
ENST00000398543.2 |
ANO1
|
anoctamin 1, calcium activated chloride channel |
chr2_+_95691445 | 3.62 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
chr20_-_23030296 | 3.60 |
ENST00000377103.2
|
THBD
|
thrombomodulin |
chr1_+_155178481 | 3.58 |
ENST00000368376.3
|
MTX1
|
metaxin 1 |
chr8_+_86376081 | 3.58 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
chr9_-_19127474 | 3.58 |
ENST00000380465.3
ENST00000380464.3 ENST00000411567.1 ENST00000276914.2 |
PLIN2
|
perilipin 2 |
chr21_+_45161301 | 3.56 |
ENST00000467908.1
|
PDXK
|
pyridoxal (pyridoxine, vitamin B6) kinase |
chr1_-_17304771 | 3.55 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
chr1_+_32042105 | 3.53 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr16_-_85784718 | 3.53 |
ENST00000602766.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
chr15_-_74501360 | 3.52 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
chr9_+_128509624 | 3.51 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr16_-_85784557 | 3.49 |
ENST00000602675.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
chr2_-_72375167 | 3.47 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
chr1_+_150480576 | 3.46 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
chr2_-_216300784 | 3.45 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr16_+_66638616 | 3.41 |
ENST00000564060.1
ENST00000565922.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr16_+_66638567 | 3.38 |
ENST00000567572.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr20_-_56284816 | 3.36 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr10_-_17659234 | 3.34 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr14_-_75079026 | 3.34 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
chr2_-_241396106 | 3.34 |
ENST00000404891.1
|
AC110619.2
|
Uncharacterized protein |
chr4_-_103266626 | 3.27 |
ENST00000356736.4
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr16_-_85784634 | 3.27 |
ENST00000284245.4
ENST00000602914.1 |
C16orf74
|
chromosome 16 open reading frame 74 |
chr6_+_151662815 | 3.26 |
ENST00000359755.5
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr15_-_74495188 | 3.25 |
ENST00000563965.1
ENST00000395105.4 |
STRA6
|
stimulated by retinoic acid 6 |
chr19_-_51017881 | 3.22 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
chr20_-_52790512 | 3.21 |
ENST00000216862.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
chr1_+_150522222 | 3.19 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
chr1_+_155178518 | 3.18 |
ENST00000316721.4
|
MTX1
|
metaxin 1 |
chr19_+_35645618 | 3.17 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr19_-_51466681 | 3.17 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr15_-_34659349 | 3.15 |
ENST00000314891.6
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
chr19_-_19051927 | 3.14 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
chr2_-_10220538 | 3.12 |
ENST00000381813.4
|
CYS1
|
cystin 1 |
chr12_+_53491220 | 3.10 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
chr19_+_676385 | 3.09 |
ENST00000166139.4
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein) |
chr9_+_139560197 | 3.07 |
ENST00000371698.3
|
EGFL7
|
EGF-like-domain, multiple 7 |
chr19_-_51472823 | 3.07 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr15_-_90039805 | 3.06 |
ENST00000544600.1
ENST00000268122.4 |
RHCG
|
Rh family, C glycoprotein |
chr6_+_151561506 | 3.04 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr7_-_38407770 | 3.03 |
ENST00000390348.2
|
TRGV1
|
T cell receptor gamma variable 1 (non-functional) |
chr1_+_150480551 | 3.02 |
ENST00000369049.4
ENST00000369047.4 |
ECM1
|
extracellular matrix protein 1 |
chr4_-_57522470 | 3.02 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
chr19_+_45349432 | 3.00 |
ENST00000252485.4
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
chr19_-_51504411 | 2.93 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
chr19_-_51456321 | 2.93 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr10_+_124221036 | 2.93 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
chr4_-_57522598 | 2.92 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
chr9_-_123639304 | 2.91 |
ENST00000436309.1
|
PHF19
|
PHD finger protein 19 |
chr12_+_119616447 | 2.88 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
chr17_-_73840415 | 2.87 |
ENST00000592386.1
ENST00000412096.2 ENST00000586147.1 |
UNC13D
|
unc-13 homolog D (C. elegans) |
chr7_-_24797546 | 2.86 |
ENST00000414428.1
ENST00000419307.1 ENST00000342947.3 |
DFNA5
|
deafness, autosomal dominant 5 |
chr8_-_144655141 | 2.85 |
ENST00000398882.3
|
MROH6
|
maestro heat-like repeat family member 6 |
chr19_-_51471362 | 2.83 |
ENST00000376853.4
ENST00000424910.2 |
KLK6
|
kallikrein-related peptidase 6 |
chr5_-_127873659 | 2.83 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
chr19_-_55658650 | 2.82 |
ENST00000589226.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr1_+_17559776 | 2.81 |
ENST00000537499.1
ENST00000413717.2 ENST00000536552.1 |
PADI1
|
peptidyl arginine deiminase, type I |
chr1_-_228603694 | 2.77 |
ENST00000366697.2
|
TRIM17
|
tripartite motif containing 17 |
chr19_-_15344243 | 2.76 |
ENST00000602233.1
|
EPHX3
|
epoxide hydrolase 3 |
chr20_-_43280361 | 2.76 |
ENST00000372874.4
|
ADA
|
adenosine deaminase |
chr9_+_139557360 | 2.76 |
ENST00000308874.7
ENST00000406555.3 ENST00000492862.2 |
EGFL7
|
EGF-like-domain, multiple 7 |
chr10_+_75670862 | 2.76 |
ENST00000446342.1
ENST00000372764.3 ENST00000372762.4 |
PLAU
|
plasminogen activator, urokinase |
chr19_-_42927251 | 2.76 |
ENST00000597001.1
|
LIPE
|
lipase, hormone-sensitive |
chr1_-_6557441 | 2.75 |
ENST00000400915.3
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr17_-_76921459 | 2.73 |
ENST00000262768.7
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr11_-_2160611 | 2.72 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr10_-_75634260 | 2.71 |
ENST00000372765.1
ENST00000351293.3 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr11_+_844067 | 2.71 |
ENST00000397406.1
ENST00000409543.2 ENST00000525201.1 |
TSPAN4
|
tetraspanin 4 |
chr19_-_51456344 | 2.67 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr20_+_306177 | 2.66 |
ENST00000544632.1
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr19_+_45418067 | 2.65 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
chr20_-_60942361 | 2.64 |
ENST00000252999.3
|
LAMA5
|
laminin, alpha 5 |
chr11_-_568369 | 2.62 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
chr11_+_69931519 | 2.61 |
ENST00000316296.5
ENST00000530676.1 |
ANO1
|
anoctamin 1, calcium activated chloride channel |
chr7_-_143059780 | 2.61 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
chr3_+_136537911 | 2.61 |
ENST00000393079.3
|
SLC35G2
|
solute carrier family 35, member G2 |
chr19_+_45281118 | 2.59 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr12_+_57522258 | 2.58 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr20_+_62327996 | 2.57 |
ENST00000369996.1
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy |
chr19_+_1450112 | 2.55 |
ENST00000590469.1
ENST00000233607.2 ENST00000238483.4 ENST00000590877.1 |
APC2
|
adenomatosis polyposis coli 2 |
chr5_-_168727713 | 2.54 |
ENST00000404867.3
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr20_-_52790055 | 2.54 |
ENST00000395955.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
chr9_+_33750667 | 2.54 |
ENST00000457896.1
ENST00000342836.4 ENST00000429677.3 |
PRSS3
|
protease, serine, 3 |
chr22_-_37640277 | 2.52 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr19_-_51487282 | 2.52 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
chr9_+_33750515 | 2.51 |
ENST00000361005.5
|
PRSS3
|
protease, serine, 3 |
chr18_+_56530136 | 2.51 |
ENST00000591083.1
|
ZNF532
|
zinc finger protein 532 |
chrX_+_134555863 | 2.51 |
ENST00000417443.2
|
LINC00086
|
long intergenic non-protein coding RNA 86 |
chr7_-_143059845 | 2.51 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
chr1_+_17531614 | 2.50 |
ENST00000375471.4
|
PADI1
|
peptidyl arginine deiminase, type I |
chr22_-_19137796 | 2.49 |
ENST00000086933.2
|
GSC2
|
goosecoid homeobox 2 |
chr3_-_52567792 | 2.48 |
ENST00000307092.4
ENST00000422318.2 ENST00000459839.1 |
NT5DC2
|
5'-nucleotidase domain containing 2 |
chr9_-_136344237 | 2.47 |
ENST00000432868.1
ENST00000371899.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr11_-_123065989 | 2.46 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
chr16_+_640201 | 2.45 |
ENST00000563109.1
|
RAB40C
|
RAB40C, member RAS oncogene family |
chr4_+_156680518 | 2.45 |
ENST00000513437.1
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
chr17_-_71410794 | 2.44 |
ENST00000424778.1
|
SDK2
|
sidekick cell adhesion molecule 2 |
chr5_+_135364584 | 2.43 |
ENST00000442011.2
ENST00000305126.8 |
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr4_-_103266219 | 2.43 |
ENST00000394833.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr21_-_44496441 | 2.43 |
ENST00000359624.3
ENST00000352178.5 |
CBS
|
cystathionine-beta-synthase |
chr21_-_44846999 | 2.43 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
chr9_-_123639445 | 2.42 |
ENST00000312189.6
|
PHF19
|
PHD finger protein 19 |
chr22_+_25003626 | 2.42 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
chr2_+_33172221 | 2.42 |
ENST00000354476.3
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr19_-_51014588 | 2.42 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
chr3_-_48594248 | 2.38 |
ENST00000545984.1
ENST00000232375.3 ENST00000416568.1 ENST00000383734.2 ENST00000541519.1 ENST00000412035.1 |
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
chr8_+_22022653 | 2.38 |
ENST00000354870.5
ENST00000397816.3 ENST00000306349.8 |
BMP1
|
bone morphogenetic protein 1 |
chr11_+_842808 | 2.37 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
chr19_-_14629224 | 2.37 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr19_-_51512804 | 2.37 |
ENST00000594211.1
ENST00000376832.4 |
KLK9
|
kallikrein-related peptidase 9 |
chr6_-_4135693 | 2.36 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr6_+_34204642 | 2.36 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
chr6_+_31371337 | 2.34 |
ENST00000449934.2
ENST00000421350.1 |
MICA
|
MHC class I polypeptide-related sequence A |
chr5_-_132112921 | 2.33 |
ENST00000378721.4
ENST00000378701.1 |
SEPT8
|
septin 8 |
chr2_-_110371412 | 2.32 |
ENST00000415095.1
ENST00000334001.6 ENST00000437928.1 ENST00000493445.1 ENST00000397714.2 ENST00000461295.1 |
SEPT10
|
septin 10 |
chr1_-_6545502 | 2.32 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chrX_-_48328631 | 2.31 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
chr17_+_6544356 | 2.30 |
ENST00000574838.1
|
TXNDC17
|
thioredoxin domain containing 17 |
chrX_-_153881842 | 2.30 |
ENST00000369585.3
ENST00000247306.4 |
CTAG2
|
cancer/testis antigen 2 |
chr1_-_204121013 | 2.29 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
chr12_-_47473707 | 2.28 |
ENST00000429635.1
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
chr15_+_90728145 | 2.27 |
ENST00000561085.1
ENST00000379122.3 ENST00000332496.6 |
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr1_-_6321035 | 2.27 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
chr4_-_175443484 | 2.27 |
ENST00000514584.1
ENST00000542498.1 ENST00000296521.7 ENST00000422112.2 ENST00000504433.1 |
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
chr7_-_93519471 | 2.26 |
ENST00000451238.1
|
TFPI2
|
tissue factor pathway inhibitor 2 |
chr1_-_204121102 | 2.25 |
ENST00000367202.4
|
ETNK2
|
ethanolamine kinase 2 |
chr1_-_6546001 | 2.25 |
ENST00000400913.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr2_-_235405679 | 2.23 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr11_+_844406 | 2.23 |
ENST00000397404.1
|
TSPAN4
|
tetraspanin 4 |
chr11_+_65686952 | 2.22 |
ENST00000527119.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr20_-_43280325 | 2.22 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
chr22_+_51112800 | 2.21 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr10_-_75634326 | 2.20 |
ENST00000322635.3
ENST00000444854.2 ENST00000423381.1 ENST00000322680.3 ENST00000394762.2 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr16_+_66638003 | 2.20 |
ENST00000562357.1
ENST00000360086.4 ENST00000562707.1 ENST00000361909.4 ENST00000460097.1 ENST00000565666.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chrX_-_48328551 | 2.19 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
chr5_-_132112907 | 2.19 |
ENST00000458488.2
|
SEPT8
|
septin 8 |
chr2_+_233925064 | 2.18 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr22_+_23264766 | 2.18 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr2_+_65215604 | 2.18 |
ENST00000531327.1
|
SLC1A4
|
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
chr1_-_6550625 | 2.17 |
ENST00000377725.1
ENST00000340850.5 |
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr1_-_113498616 | 2.17 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
chr1_-_204121298 | 2.16 |
ENST00000367199.2
|
ETNK2
|
ethanolamine kinase 2 |
chr5_-_77944648 | 2.16 |
ENST00000380345.2
|
LHFPL2
|
lipoma HMGIC fusion partner-like 2 |
chr10_+_88728189 | 2.16 |
ENST00000416348.1
|
ADIRF
|
adipogenesis regulatory factor |
chr17_+_74380683 | 2.15 |
ENST00000592299.1
ENST00000590959.1 ENST00000323374.4 |
SPHK1
|
sphingosine kinase 1 |
chr22_+_50919995 | 2.14 |
ENST00000362068.2
ENST00000395737.1 |
ADM2
|
adrenomedullin 2 |
chr6_-_30654977 | 2.14 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
chr17_+_1945301 | 2.10 |
ENST00000572195.1
|
OVCA2
|
ovarian tumor suppressor candidate 2 |
chr9_-_127269661 | 2.09 |
ENST00000373588.4
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
chr9_+_139847347 | 2.09 |
ENST00000371632.3
|
LCN12
|
lipocalin 12 |
chr17_+_7942424 | 2.09 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
chr17_+_7942335 | 2.09 |
ENST00000380183.4
ENST00000572022.1 ENST00000380173.2 |
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
chr1_-_204116078 | 2.08 |
ENST00000367198.2
ENST00000452983.1 |
ETNK2
|
ethanolamine kinase 2 |
chrX_+_134166333 | 2.08 |
ENST00000257013.7
|
FAM127A
|
family with sequence similarity 127, member A |
chr16_-_90085824 | 2.07 |
ENST00000002501.6
|
DBNDD1
|
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
chr1_-_93426998 | 2.07 |
ENST00000370310.4
|
FAM69A
|
family with sequence similarity 69, member A |
chr2_-_31361543 | 2.07 |
ENST00000349752.5
|
GALNT14
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
chr19_-_11689752 | 2.05 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
chr7_-_38370536 | 2.05 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
chr9_-_131644306 | 2.05 |
ENST00000302586.3
|
CCBL1
|
cysteine conjugate-beta lyase, cytoplasmic |
chr1_+_155179012 | 2.05 |
ENST00000609421.1
|
MTX1
|
metaxin 1 |
chr2_-_208031542 | 2.04 |
ENST00000423015.1
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.5 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
2.2 | 13.5 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
2.0 | 10.1 | GO:0061143 | alveolar primary septum development(GO:0061143) |
2.0 | 6.0 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
2.0 | 7.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
2.0 | 2.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.9 | 5.8 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
1.8 | 5.4 | GO:0042938 | dipeptide transport(GO:0042938) |
1.6 | 14.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
1.5 | 4.6 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
1.5 | 4.4 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
1.4 | 5.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
1.4 | 4.1 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
1.3 | 2.6 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
1.3 | 6.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.2 | 8.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.2 | 3.7 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
1.2 | 2.4 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
1.2 | 26.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.2 | 6.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.2 | 3.6 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
1.2 | 9.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.2 | 3.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.2 | 1.2 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
1.1 | 3.4 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
1.1 | 3.4 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
1.1 | 1.1 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
1.1 | 3.3 | GO:0097187 | dentinogenesis(GO:0097187) |
1.1 | 12.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.1 | 8.9 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
1.1 | 6.5 | GO:0030421 | defecation(GO:0030421) |
1.1 | 3.3 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
1.0 | 4.0 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
1.0 | 4.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.0 | 8.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.0 | 5.7 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.9 | 3.8 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.9 | 2.8 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.9 | 2.8 | GO:0035623 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
0.9 | 2.8 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.9 | 2.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.9 | 10.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.9 | 2.7 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.9 | 8.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.9 | 2.6 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.8 | 4.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.8 | 4.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.8 | 2.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.8 | 1.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.8 | 5.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.8 | 1.6 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.8 | 4.1 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.8 | 6.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.8 | 4.8 | GO:0032252 | secretory granule localization(GO:0032252) |
0.8 | 6.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.8 | 3.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.8 | 1.6 | GO:0032196 | transposition(GO:0032196) |
0.8 | 3.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.8 | 2.3 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.8 | 0.8 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.8 | 2.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 0.7 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.7 | 6.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.7 | 0.7 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.7 | 2.2 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.7 | 2.2 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.7 | 0.7 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.7 | 6.3 | GO:0015705 | iodide transport(GO:0015705) |
0.7 | 3.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.7 | 4.2 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.7 | 3.5 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.7 | 0.7 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.7 | 10.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.7 | 2.0 | GO:0051796 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.7 | 0.7 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.7 | 2.0 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.7 | 1.3 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.6 | 2.6 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.6 | 3.9 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.6 | 1.9 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.6 | 2.5 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.6 | 0.6 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.6 | 7.5 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.6 | 7.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.6 | 3.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 8.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.6 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.6 | 2.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 11.0 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.6 | 3.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.6 | 1.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.6 | 1.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.6 | 1.8 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.6 | 2.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.6 | 0.6 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.6 | 4.8 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.6 | 1.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.6 | 2.9 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.6 | 2.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.6 | 14.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.6 | 2.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.6 | 1.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 0.6 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.6 | 0.6 | GO:0060324 | face development(GO:0060324) |
0.6 | 1.7 | GO:0071790 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.6 | 3.4 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.6 | 1.7 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.6 | 5.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 3.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.6 | 3.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.6 | 1.7 | GO:0002384 | hepatic immune response(GO:0002384) |
0.6 | 3.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.6 | 1.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.5 | 0.5 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.5 | 4.4 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.5 | 2.7 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.5 | 1.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.5 | 2.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.5 | 1.6 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.5 | 5.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.5 | 2.1 | GO:1901204 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.5 | 2.1 | GO:0007538 | primary sex determination(GO:0007538) |
0.5 | 1.0 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.5 | 1.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 3.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.5 | 1.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.5 | 1.0 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.5 | 4.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.5 | 0.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.5 | 1.0 | GO:0010165 | response to X-ray(GO:0010165) |
0.5 | 2.5 | GO:0060356 | leucine import(GO:0060356) |
0.5 | 2.5 | GO:1990834 | response to odorant(GO:1990834) |
0.5 | 0.5 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
0.5 | 1.5 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.5 | 1.5 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.5 | 2.0 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.5 | 3.0 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.5 | 2.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.5 | 3.0 | GO:0014028 | notochord formation(GO:0014028) |
0.5 | 2.5 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.5 | 2.0 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.5 | 1.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.5 | 1.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 1.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.5 | 2.9 | GO:0042335 | cuticle development(GO:0042335) |
0.5 | 1.0 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.5 | 10.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.5 | 1.4 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.5 | 0.9 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 1.4 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.5 | 0.5 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.5 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.5 | 0.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.5 | 2.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 0.9 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
0.5 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 0.9 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.5 | 1.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.5 | 1.8 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.5 | 2.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 3.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.5 | 1.4 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.5 | 3.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.5 | 1.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.5 | 1.4 | GO:0060426 | lung vasculature development(GO:0060426) |
0.4 | 5.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 7.1 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.4 | 0.4 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.4 | 1.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 1.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 4.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.4 | 1.8 | GO:1904647 | response to rotenone(GO:1904647) |
0.4 | 0.4 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.4 | 0.9 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.4 | 2.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.4 | 0.4 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.4 | 1.3 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.4 | 1.7 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 5.5 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 1.3 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.4 | 1.7 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.4 | 2.5 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.4 | 1.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) negative regulation of membrane tubulation(GO:1903526) |
0.4 | 2.9 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.4 | 1.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.4 | 0.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.4 | 1.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 0.8 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.4 | 1.2 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.4 | 2.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.4 | 0.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 0.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.4 | 1.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.4 | 1.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.4 | 1.2 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.4 | 9.4 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.4 | 2.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.4 | 4.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.4 | 2.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 11.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 5.3 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 2.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.4 | 0.8 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.4 | 1.2 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.4 | 1.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.4 | 3.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.4 | 2.0 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.4 | 0.8 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.4 | 4.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 9.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.4 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 3.2 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.4 | 1.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.4 | 1.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.4 | 3.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 1.2 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 5.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.4 | 5.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 3.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.4 | 1.5 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.4 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.4 | 3.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 1.9 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.4 | 1.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 1.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.4 | 1.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 3.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 1.1 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.4 | 1.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 2.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.4 | 4.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 0.4 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.4 | 1.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.4 | 2.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 0.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.4 | 2.6 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 1.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.4 | 4.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.5 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.4 | 1.1 | GO:0030728 | ovulation(GO:0030728) |
0.4 | 1.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.4 | 5.4 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.4 | 0.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.4 | 0.4 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.4 | 2.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 1.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.4 | 1.4 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.4 | 1.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 1.1 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.4 | 2.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.4 | 2.1 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.4 | 0.4 | GO:0001823 | ureteric bud development(GO:0001657) mesonephros development(GO:0001823) |
0.4 | 1.1 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.4 | 1.1 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.3 | 2.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.3 | 0.3 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.3 | 1.0 | GO:0030300 | negative regulation of intestinal phytosterol absorption(GO:0010949) regulation of intestinal cholesterol absorption(GO:0030300) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) regulation of intestinal lipid absorption(GO:1904729) negative regulation of intestinal lipid absorption(GO:1904730) |
0.3 | 1.0 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.3 | 1.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 1.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.3 | 3.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.7 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
0.3 | 0.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.3 | 1.0 | GO:0050894 | determination of affect(GO:0050894) |
0.3 | 1.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 1.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 4.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 2.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 0.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 2.7 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.3 | 1.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 0.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.3 | 1.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 0.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 2.0 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.3 | 1.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.3 | 1.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 1.0 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.3 | 0.7 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.3 | 6.8 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.3 | 1.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 1.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 2.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.3 | 1.0 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.3 | 2.3 | GO:0060992 | response to fungicide(GO:0060992) |
0.3 | 1.6 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.3 | 0.3 | GO:0051604 | protein maturation(GO:0051604) |
0.3 | 0.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.3 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 1.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.3 | 1.9 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.3 | 3.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.6 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.3 | 1.6 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
0.3 | 2.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 1.9 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.3 | 1.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.3 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.3 | 0.3 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.3 | 0.3 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.3 | 1.2 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.3 | 0.6 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.3 | 1.2 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.9 | GO:0005985 | sucrose metabolic process(GO:0005985) |
0.3 | 0.9 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.3 | 1.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.3 | 0.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.3 | 0.6 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.3 | 0.6 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.3 | 0.9 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.3 | 0.6 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.3 | 1.5 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.3 | 0.9 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.3 | 1.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 0.6 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.3 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.6 | GO:0021623 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.3 | 1.5 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.3 | 7.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 0.9 | GO:0071848 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.3 | 1.2 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.3 | 1.2 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.3 | 1.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 3.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.6 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.3 | 1.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 1.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 2.7 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.3 | 0.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.3 | 2.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 2.7 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 1.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.3 | 0.3 | GO:0071242 | response to ammonium ion(GO:0060359) cellular response to ammonium ion(GO:0071242) |
0.3 | 9.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 2.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.6 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.3 | 0.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 7.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 0.6 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.3 | 0.9 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.3 | 4.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 1.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 2.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 1.7 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.3 | 2.3 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 0.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 1.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.3 | 1.1 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.3 | 1.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.3 | 4.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.3 | 0.3 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.3 | 1.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.3 | 0.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.3 | 2.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 1.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 1.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.3 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.3 | 1.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 0.3 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.3 | 0.6 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.3 | 0.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.3 | 0.5 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 1.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.3 | 0.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.3 | 2.2 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.3 | 1.1 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.3 | 1.4 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.3 | 0.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 0.8 | GO:0048627 | myoblast development(GO:0048627) |
0.3 | 1.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.3 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 3.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 2.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 0.3 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.3 | 0.5 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.3 | 9.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.3 | 0.8 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.3 | 0.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
0.3 | 0.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.8 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) cellular response to luteinizing hormone stimulus(GO:0071373) |
0.3 | 1.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 1.8 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.3 | 1.0 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 3.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 0.3 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.3 | 0.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.8 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) |
0.3 | 1.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 8.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 0.8 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 0.8 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.3 | 0.3 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.3 | 3.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.8 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.3 | 1.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.3 | 2.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 1.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 2.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.3 | 0.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.8 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
0.3 | 3.0 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.3 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.3 | 0.3 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.3 | 1.0 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.3 | 0.5 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.3 | 2.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 1.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.2 | 3.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 1.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 1.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 2.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 3.4 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.5 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.2 | 1.2 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 2.4 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 1.7 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 1.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 1.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 1.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 0.7 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 2.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.2 | 0.2 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.2 | 1.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 4.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.2 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 4.3 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 4.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 0.5 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 4.5 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.2 | 0.2 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.2 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 2.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 1.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.2 | 0.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.7 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.2 | 0.9 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.5 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.2 | 1.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 2.8 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.2 | 1.2 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.2 | 0.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 | 1.4 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.2 | 0.7 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 1.2 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.2 | 1.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.9 | GO:1990910 | response to hypobaric hypoxia(GO:1990910) |
0.2 | 0.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.2 | 1.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 2.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 0.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.7 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.2 | 0.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 1.6 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.2 | 0.7 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 1.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 1.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 2.9 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 1.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 1.1 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 0.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 1.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 1.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.2 | 0.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.2 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.2 | 0.7 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.2 | GO:0021539 | subthalamus development(GO:0021539) |
0.2 | 2.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 5.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 3.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 1.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 4.8 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 2.4 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 0.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.2 | 0.7 | GO:1904344 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.2 | 0.4 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.2 | 0.2 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
0.2 | 1.7 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.9 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 1.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.9 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.2 | 1.7 | GO:0046618 | drug export(GO:0046618) |
0.2 | 3.0 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.2 | 0.4 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 0.9 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 1.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.2 | 2.1 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 2.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 2.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 1.3 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.2 | 1.3 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 1.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 5.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.2 | 0.2 | GO:0071451 | response to superoxide(GO:0000303) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.2 | 3.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 1.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.8 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.2 | 1.0 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 1.5 | GO:1900045 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 0.8 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.2 | 0.2 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.2 | 0.4 | GO:0061056 | sclerotome development(GO:0061056) |
0.2 | 2.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 1.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 0.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 0.8 | GO:0003335 | corneocyte development(GO:0003335) |
0.2 | 2.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.6 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.2 | 0.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.2 | 2.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 9.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.2 | 2.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.2 | 0.4 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.2 | 0.6 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.2 | 1.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.2 | 0.6 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.2 | 0.6 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 1.0 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 1.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 2.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.6 | GO:0009750 | response to fructose(GO:0009750) |
0.2 | 0.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.4 | GO:0038001 | paracrine signaling(GO:0038001) |
0.2 | 0.8 | GO:0048483 | autonomic nervous system development(GO:0048483) |
0.2 | 0.2 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.2 | 2.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.2 | GO:0072254 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
0.2 | 0.6 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.2 | 1.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 1.8 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.2 | 2.7 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.2 | 1.2 | GO:0006574 | valine catabolic process(GO:0006574) |
0.2 | 0.6 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.2 | 0.4 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.2 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.6 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.2 | 0.6 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.2 | 0.6 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.2 | 0.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 1.2 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 0.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 0.8 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.2 | 0.8 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.2 | GO:0071560 | cellular response to transforming growth factor beta stimulus(GO:0071560) |
0.2 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 4.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 3.8 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.2 | 1.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 1.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) |
0.2 | 0.4 | GO:0042596 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
0.2 | 2.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 2.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.2 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 2.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 0.2 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.2 | 1.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 1.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.9 | GO:0035814 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of renal sodium excretion(GO:0035814) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
0.2 | 1.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 1.6 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.9 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.2 | 0.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 6.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.2 | 0.9 | GO:0035909 | aorta morphogenesis(GO:0035909) |
0.2 | 1.1 | GO:1901907 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.2 | 0.5 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 4.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 0.4 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 0.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.9 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.2 | 0.4 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.2 | 1.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.2 | 0.2 | GO:0032680 | regulation of tumor necrosis factor production(GO:0032680) |
0.2 | 1.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.2 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.2 | 2.6 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.2 | 0.5 | GO:0030817 | regulation of cAMP biosynthetic process(GO:0030817) |
0.2 | 3.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.2 | 1.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.2 | 0.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.2 | 0.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 0.5 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.2 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.2 | 1.7 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.2 | 0.7 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
0.2 | 1.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.2 | 0.3 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.2 | 0.8 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.2 | 0.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.2 | 2.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.2 | 0.3 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.2 | 1.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 1.0 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.2 | 1.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.8 | GO:0032218 | riboflavin transport(GO:0032218) |
0.2 | 1.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 1.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.3 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.2 | 2.0 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.2 | 2.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 3.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 2.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 1.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.2 | 1.5 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.2 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 1.5 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.2 | 2.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.5 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.2 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 1.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.8 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.2 | 1.0 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.2 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.5 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 1.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 10.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.8 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 2.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 1.3 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) negative regulation of necrotic cell death(GO:0060547) |
0.2 | 0.3 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.2 | 2.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.8 | GO:0007622 | rhythmic behavior(GO:0007622) |
0.2 | 1.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 1.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 1.0 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.2 | 0.2 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.2 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.2 | 1.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 4.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.5 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.2 | 0.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 1.1 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.2 | 0.2 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.2 | 1.1 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.2 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 1.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 0.9 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.2 | 0.8 | GO:0048749 | compound eye development(GO:0048749) |
0.2 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.9 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 0.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 2.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 1.8 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 2.0 | GO:0001825 | blastocyst formation(GO:0001825) |
0.2 | 3.4 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.2 | 4.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 0.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.2 | 0.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 0.8 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.2 | 0.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 1.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 0.8 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.2 | 8.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 3.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 1.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.2 | 0.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 0.5 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 | 0.9 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 2.2 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 1.8 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.9 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 0.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 2.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.1 | 0.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 1.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 1.0 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.4 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.1 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 1.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 2.0 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.4 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 0.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 1.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 0.4 | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.1 | 0.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.3 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 1.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.9 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 1.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 1.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.4 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.1 | 0.6 | GO:1905123 | regulation of endosome organization(GO:1904978) regulation of glucosylceramidase activity(GO:1905123) |
0.1 | 1.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.3 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.3 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.1 | 1.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.6 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 4.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 1.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 1.2 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.1 | 1.9 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 1.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 3.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 1.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 2.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 1.4 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.1 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 1.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.4 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) negative regulation of triglyceride catabolic process(GO:0010897) negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.4 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
0.1 | 1.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.5 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 0.4 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.1 | 0.3 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.5 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 3.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.4 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 2.2 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.1 | 0.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.9 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.7 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 0.8 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 1.3 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.1 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.4 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.1 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 1.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.5 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.1 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.1 | 0.6 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.9 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.4 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.1 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 1.0 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.1 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.4 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.1 | 0.6 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.1 | 0.8 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 0.5 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.1 | 0.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.3 | GO:0034614 | cellular response to reactive oxygen species(GO:0034614) |
0.1 | 1.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.4 | GO:0018194 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.1 | 0.1 | GO:0021761 | limbic system development(GO:0021761) |
0.1 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 1.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 1.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 2.0 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.6 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.5 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.6 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.4 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.1 | 0.5 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.9 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 5.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 5.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 1.0 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.5 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 3.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.1 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.1 | 4.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.1 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 1.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.1 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 1.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.5 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 2.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.1 | 1.3 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 2.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.8 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.1 | 0.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 1.2 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.1 | 0.6 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 5.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.5 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.3 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.9 | GO:0060026 | convergent extension(GO:0060026) |
0.1 | 3.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 1.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 2.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.9 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.1 | 3.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.9 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.9 | GO:0009209 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.1 | 2.4 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 0.7 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 1.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 2.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 1.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 1.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 1.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 0.3 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.1 | 0.7 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 3.4 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 0.1 | GO:2000506 | negative regulation of energy homeostasis(GO:2000506) |
0.1 | 1.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 1.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.1 | 0.9 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.2 | GO:0034755 | copper ion import(GO:0015677) ferric iron import(GO:0033216) iron ion transmembrane transport(GO:0034755) iron ion import(GO:0097286) iron ion import into cell(GO:0097459) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) iron ion import across plasma membrane(GO:0098711) |
0.1 | 0.2 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.1 | 1.6 | GO:0098868 | bone growth(GO:0098868) |
0.1 | 0.2 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.1 | 0.6 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 0.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 2.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 1.2 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.2 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.1 | 3.0 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.1 | 0.5 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.1 | 0.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 3.7 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
0.1 | 0.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 1.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.1 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 1.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 1.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 1.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.4 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.1 | 0.7 | GO:0001666 | response to hypoxia(GO:0001666) |
0.1 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 2.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 1.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.8 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.7 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.3 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.1 | 1.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 0.2 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.1 | 0.3 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 1.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.1 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 1.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 1.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.1 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 1.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.1 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
0.1 | 0.7 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.3 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 1.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 1.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.6 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.1 | 0.5 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.3 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.1 | 1.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.3 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 1.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 2.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.4 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.1 | 0.3 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.1 | 0.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 11.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.4 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.1 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.1 | 0.5 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.7 | GO:0046078 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.1 | 0.3 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.5 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 0.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.2 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.1 | 0.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.7 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 2.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.8 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 0.7 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.2 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 2.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.2 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.1 | 1.1 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 1.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.2 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.1 | 4.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.8 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.2 | GO:0071529 | cementum mineralization(GO:0071529) |
0.1 | 0.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 0.6 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 1.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 0.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.2 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.1 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.1 | 0.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.4 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 4.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.1 | 1.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.1 | 0.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 3.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 2.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.6 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.1 | 0.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.7 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.4 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.1 | GO:0042363 | fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.8 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.7 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.2 | GO:0050893 | sensory processing(GO:0050893) |
0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 1.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 2.7 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 1.7 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.1 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.1 | 1.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 1.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.4 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 3.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.1 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.1 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.1 | 0.1 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.1 | 0.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.2 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.1 | 0.1 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.1 | 1.4 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.1 | GO:0003285 | septum secundum development(GO:0003285) |
0.1 | 0.3 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 1.0 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.2 | GO:0006533 | aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
0.1 | 0.3 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 0.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 2.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.1 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.1 | 0.3 | GO:0035546 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) |
0.1 | 0.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.3 | GO:0042310 | vasoconstriction(GO:0042310) |
0.1 | 0.3 | GO:0043306 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.6 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 0.5 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 1.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.1 | GO:0016571 | histone methylation(GO:0016571) |
0.1 | 0.5 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.3 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
0.1 | 0.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.9 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.1 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.8 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.7 | GO:0007626 | locomotory behavior(GO:0007626) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.4 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.1 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 1.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.5 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.6 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.1 | 0.2 | GO:0003231 | cardiac ventricle development(GO:0003231) |
0.1 | 0.6 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.5 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.3 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.1 | 0.2 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.4 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 1.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 1.8 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.3 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.1 | 0.1 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.2 | GO:0071502 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 3.2 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 1.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 1.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:1903707 | negative regulation of hemopoiesis(GO:1903707) |
0.1 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.3 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 1.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 1.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.2 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.1 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.2 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.1 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.1 | GO:0072665 | protein localization to vacuole(GO:0072665) |
0.1 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.1 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.2 | GO:0021503 | neural fold bending(GO:0021503) |
0.1 | 0.1 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
0.1 | 0.3 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.2 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.6 | GO:0060544 | regulation of necroptotic process(GO:0060544) |
0.1 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.2 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.1 | 1.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.3 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.1 | 0.4 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) |
0.1 | 1.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 0.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 0.6 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.1 | GO:0052553 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.2 | GO:0002818 | intracellular defense response(GO:0002818) |
0.1 | 0.4 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.1 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.7 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.4 | GO:0048511 | rhythmic process(GO:0048511) |
0.1 | 0.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.4 | GO:0071383 | cellular response to steroid hormone stimulus(GO:0071383) |
0.1 | 1.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.4 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.1 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 1.7 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 1.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.5 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 2.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 2.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0003279 | cardiac septum development(GO:0003279) |
0.0 | 0.2 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.6 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.0 | 0.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.5 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 0.3 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.1 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.0 | 0.4 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.2 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.0 | 0.2 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.0 | 0.1 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.0 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.2 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 2.5 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.0 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.7 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.0 | 0.0 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:1902576 | negative regulation of nuclear cell cycle DNA replication(GO:1902576) |
0.0 | 1.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) regulation of branching morphogenesis of a nerve(GO:2000172) |
0.0 | 0.1 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 0.1 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.2 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.0 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.1 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.0 | 0.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.4 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.0 | 0.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 1.3 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 2.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.0 | 0.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.2 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.0 | 1.3 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.3 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 1.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.0 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.2 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.0 | 0.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.0 | 1.0 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.7 | GO:0071345 | cellular response to cytokine stimulus(GO:0071345) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.0 | 0.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.2 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.1 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 1.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 1.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.0 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.0 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.0 | 0.2 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.0 | 0.1 | GO:0034184 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.0 | 0.8 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.0 | 0.9 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.0 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.0 | 0.1 | GO:0015942 | formate metabolic process(GO:0015942) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.3 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.2 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.3 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.2 | GO:0036473 | cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.2 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.0 | 0.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.0 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.3 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.6 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090100) |
0.0 | 0.0 | GO:1903539 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) protein localization to postsynaptic membrane(GO:1903539) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.0 | 0.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.0 | GO:0055081 | anion homeostasis(GO:0055081) |
0.0 | 0.0 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.0 | 0.6 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.8 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.0 | 0.0 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.0 | 0.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 1.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.3 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.2 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.1 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.5 | GO:0030036 | actin cytoskeleton organization(GO:0030036) |
0.0 | 0.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.0 | 0.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 1.8 | GO:0007411 | axon guidance(GO:0007411) |
0.0 | 0.0 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.2 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.2 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 1.4 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 0.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.0 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.0 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.0 | GO:0043144 | snoRNA processing(GO:0043144) |
0.0 | 0.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.1 | GO:0006096 | glycolytic process(GO:0006096) |
0.0 | 1.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.2 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 13.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.6 | 6.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.4 | 1.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.2 | 3.6 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
1.0 | 4.0 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
1.0 | 4.9 | GO:0032449 | CBM complex(GO:0032449) |
0.9 | 3.6 | GO:0045160 | myosin I complex(GO:0045160) |
0.9 | 4.4 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.9 | 2.6 | GO:0071065 | dense core granule membrane(GO:0032127) alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.9 | 2.6 | GO:1990032 | parallel fiber(GO:1990032) |
0.9 | 21.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.8 | 2.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 6.9 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.7 | 0.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.7 | 2.1 | GO:0031523 | Myb complex(GO:0031523) |
0.7 | 2.0 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.7 | 6.1 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.6 | 1.8 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.6 | 10.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.6 | 0.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.6 | 1.7 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.6 | 1.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 1.6 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.5 | 1.6 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.5 | 2.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.5 | 7.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 0.5 | GO:0044301 | climbing fiber(GO:0044301) |
0.5 | 3.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 5.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 0.5 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.5 | 2.8 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.5 | 1.4 | GO:1990031 | pinceau fiber(GO:1990031) |
0.4 | 1.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.4 | 3.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 2.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 2.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 0.4 | GO:0051286 | cell tip(GO:0051286) |
0.4 | 0.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.4 | 5.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 6.5 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 2.0 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.4 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 10.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 2.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.4 | 1.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.4 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 14.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 2.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.4 | 0.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 1.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 1.8 | GO:0035838 | growing cell tip(GO:0035838) |
0.4 | 2.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.4 | 6.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.4 | 0.4 | GO:0000806 | Y chromosome(GO:0000806) |
0.4 | 4.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 2.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 3.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.3 | 5.0 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 2.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.3 | 1.6 | GO:0044393 | microspike(GO:0044393) |
0.3 | 0.3 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.3 | 0.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 2.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 7.4 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 1.2 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.8 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.3 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 1.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 0.9 | GO:0044609 | DBIRD complex(GO:0044609) |
0.3 | 3.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 1.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.3 | 1.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 1.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 1.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.3 | 2.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 11.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 1.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.3 | 2.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.6 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.3 | 1.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 0.8 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.3 | 0.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.3 | 0.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 3.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 0.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 6.2 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 1.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.3 | 1.3 | GO:0031905 | early endosome lumen(GO:0031905) |
0.3 | 4.8 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.3 | 2.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 1.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 2.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 1.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 4.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 3.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.7 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.2 | 2.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 5.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 0.7 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 0.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 3.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 1.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.2 | 4.2 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 3.6 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 1.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 6.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 4.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 4.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 1.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 8.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 0.6 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.2 | 0.8 | GO:0014802 | terminal cisterna(GO:0014802) |
0.2 | 0.4 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 1.7 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 1.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.2 | 1.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.2 | 0.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 2.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.6 | GO:0016938 | kinesin I complex(GO:0016938) |
0.2 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 2.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 2.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 3.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 15.6 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 2.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.2 | 0.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 1.6 | GO:0032059 | bleb(GO:0032059) |
0.2 | 1.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 2.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 1.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 1.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 5.3 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.9 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.6 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 2.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.2 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 0.6 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.2 | 1.9 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 1.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.2 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 4.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 1.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 1.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 2.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 1.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 4.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.7 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 0.7 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 2.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.3 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.1 | 0.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 1.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 12.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 1.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 2.6 | GO:0031253 | cell projection membrane(GO:0031253) |
0.1 | 0.4 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 7.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 1.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.1 | 0.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.4 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.1 | 88.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 2.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.3 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.1 | 0.4 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.1 | 0.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 1.1 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 5.1 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 2.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 2.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.4 | GO:0031988 | cytoplasmic, membrane-bounded vesicle(GO:0016023) membrane-bounded vesicle(GO:0031988) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.7 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 1.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.5 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 10.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 2.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.4 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 1.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.2 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.1 | 0.2 | GO:0044753 | amphisome(GO:0044753) |
0.1 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 1.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 3.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 10.4 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 2.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.7 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 0.8 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 4.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.5 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 0.9 | GO:0031982 | vesicle(GO:0031982) |
0.1 | 0.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 2.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 4.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 2.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 3.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.7 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 3.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.6 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 4.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.7 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.9 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 2.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.1 | 1.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 2.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.9 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 4.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.3 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.1 | 1.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 6.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 2.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.6 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 1.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.7 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 1.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 19.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 1.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.1 | 0.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 7.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 4.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 6.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.3 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.2 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.2 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
0.1 | 35.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.8 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 7.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 8.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 9.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 13.4 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.1 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.3 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 1.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 2.2 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 3.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 4.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 2.4 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 0.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 2.3 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 2.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 1.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 2.6 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.3 | GO:0070985 | TFIIK complex(GO:0070985) |
0.1 | 1.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 3.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 9.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 1.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.6 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.1 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 1.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.6 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.5 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 0.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 6.5 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 11.0 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.1 | 1.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 6.0 | GO:0070161 | anchoring junction(GO:0070161) |
0.1 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 1.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 2.7 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.2 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.2 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 7.0 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.1 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 1.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.2 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 0.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 4.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.2 | GO:0032806 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 4.4 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 1.0 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 7.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 1.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 2.9 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.1 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.1 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.0 | 1.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 2.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.0 | 0.7 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.0 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.0 | 1.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.5 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 3.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.1 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 1.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 1.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 2.4 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 2.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.0 | 1.3 | GO:0034702 | ion channel complex(GO:0034702) |
0.0 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.1 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.0 | 0.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 2.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 1.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 2.9 | GO:0045121 | membrane raft(GO:0045121) |
0.0 | 3.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 1.7 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 1.6 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 0.0 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 2.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.0 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.0 | 0.1 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.4 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.2 | GO:0005903 | brush border(GO:0005903) |
0.0 | 1.8 | GO:0098794 | postsynapse(GO:0098794) |
0.0 | 1.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 1.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.1 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.0 | 0.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 3.4 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 13.9 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | GO:0098809 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
1.5 | 7.5 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
1.5 | 4.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.4 | 5.5 | GO:0030395 | lactose binding(GO:0030395) |
1.4 | 4.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
1.4 | 4.1 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
1.3 | 5.3 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
1.3 | 6.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.2 | 6.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.2 | 3.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.2 | 3.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
1.1 | 3.4 | GO:0008478 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
1.1 | 3.4 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
1.1 | 5.4 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.0 | 4.0 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
1.0 | 4.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.0 | 14.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.0 | 2.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.0 | 9.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.9 | 13.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.9 | 7.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.9 | 1.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.9 | 4.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.9 | 4.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.9 | 3.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.9 | 2.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.9 | 4.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.8 | 3.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.8 | 4.9 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.8 | 2.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.8 | 4.0 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.8 | 4.0 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.8 | 3.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.8 | 3.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.8 | 3.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.7 | 6.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.7 | 6.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 2.2 | GO:0032093 | SAM domain binding(GO:0032093) |
0.7 | 2.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 2.7 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.7 | 9.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.7 | 2.6 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.6 | 2.6 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.6 | 3.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.6 | 0.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.6 | 9.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 5.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 2.6 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.6 | 6.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.6 | 1.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.6 | 1.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.6 | 11.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.6 | 1.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.6 | 5.4 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.6 | 3.5 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.6 | 1.8 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.6 | 1.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.6 | 1.7 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.6 | 2.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.6 | 2.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 1.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.6 | 2.2 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.5 | 6.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.5 | 2.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.5 | 3.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.5 | 1.6 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.5 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 2.1 | GO:0008431 | vitamin E binding(GO:0008431) |
0.5 | 2.6 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 3.7 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.5 | 3.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 2.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.5 | 2.6 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
0.5 | 1.5 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.5 | 8.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 2.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.5 | 4.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 2.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.5 | 2.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 1.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.5 | 1.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 1.5 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.5 | 0.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 1.4 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.5 | 1.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.5 | 1.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.5 | 2.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.5 | 1.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.5 | 3.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 4.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 2.8 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.5 | 1.8 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.5 | 0.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.5 | 1.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 1.4 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.4 | 10.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 2.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 5.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.4 | 1.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 3.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 3.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 1.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.4 | 7.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 1.7 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.4 | 1.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.4 | 1.2 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.4 | 1.2 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.4 | 1.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 8.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 2.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 1.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.4 | 1.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 2.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 1.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 1.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 3.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 1.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 1.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.4 | 1.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.4 | 1.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.4 | 2.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.4 | 6.5 | GO:0048185 | activin binding(GO:0048185) |
0.4 | 0.4 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.4 | 1.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.4 | 1.8 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.4 | 1.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 1.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 1.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.3 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 1.0 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.3 | 1.0 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.3 | 0.7 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.3 | 1.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.0 | GO:0070984 | SET domain binding(GO:0070984) |
0.3 | 2.0 | GO:0042835 | BRE binding(GO:0042835) |
0.3 | 2.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 1.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 1.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.3 | 2.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 2.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 2.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 1.3 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 2.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 2.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.3 | 5.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.0 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.3 | 1.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 9.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 1.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 0.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 3.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.3 | 0.9 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.3 | 11.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 98.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 0.9 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.3 | 1.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.3 | 1.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.3 | 0.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.3 | 7.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 4.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 3.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 0.3 | GO:0000035 | acyl binding(GO:0000035) |
0.3 | 3.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 3.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 5.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 2.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 3.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 2.7 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 2.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 4.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 1.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.3 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 0.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 1.7 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.3 | 1.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.3 | 0.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.3 | 2.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 9.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 3.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 2.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.3 | 7.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 1.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 1.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.3 | 1.6 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.3 | 1.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 6.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 6.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 1.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 0.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 2.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 1.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.3 | 10.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 6.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 3.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.3 | 4.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.3 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 2.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 3.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 1.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 0.8 | GO:0051861 | glycolipid binding(GO:0051861) |
0.3 | 1.5 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 5.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 0.8 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.3 | 4.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 1.3 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.3 | 2.0 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 4.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 2.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.7 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.2 | 1.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 1.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 2.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 2.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.7 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.2 | 0.2 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.2 | 1.0 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.2 | 3.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 0.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 1.0 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.2 | 1.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 2.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 5.5 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 0.5 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 2.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.7 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.2 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 1.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.9 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.2 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.5 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.2 | 1.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 13.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 5.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 4.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.7 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.2 | 0.7 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.2 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 1.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.9 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 3.8 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 1.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 3.8 | GO:0043295 | glutathione binding(GO:0043295) |
0.2 | 2.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 3.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 0.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 3.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.2 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 0.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 2.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 1.0 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.8 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.2 | 0.6 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.2 | 0.6 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 11.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.4 | GO:0005503 | all-trans retinal binding(GO:0005503) |
0.2 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.8 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 0.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.2 | 1.0 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.2 | 1.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 1.0 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.2 | 0.8 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.2 | 1.2 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.2 | 1.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 1.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 2.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.6 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.2 | 4.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.2 | 3.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.6 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.2 | 0.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.2 | 0.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 0.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.2 | 0.8 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.2 | 3.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 2.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.0 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.2 | 1.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.6 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.8 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 0.6 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.2 | 2.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.2 | 2.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 1.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 1.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.7 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.2 | 1.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.2 | 1.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.5 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.2 | 5.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 1.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 1.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.2 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.2 | 0.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.2 | 4.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 1.1 | GO:0052848 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.2 | 0.7 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.2 | 5.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.5 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.2 | 1.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.2 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.3 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 1.7 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 6.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 2.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 1.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 3.6 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.2 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.9 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.2 | 1.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 1.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.5 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.2 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 2.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 1.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.8 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 0.7 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.2 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 1.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.5 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.2 | 3.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 15.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.5 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.2 | 1.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 1.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 1.0 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.5 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.2 | 22.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 2.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 4.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.6 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 0.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 1.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.3 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.2 | 2.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.2 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 4.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 2.9 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 19.6 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 6.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.3 | GO:0015165 | nucleotide-sugar transmembrane transporter activity(GO:0005338) pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 1.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 2.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 2.1 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 1.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 1.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.7 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.1 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.9 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 5.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.7 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.1 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 2.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 1.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 1.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 1.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 1.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 19.6 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 2.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 1.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 2.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.1 | 2.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.5 | GO:0008443 | 6-phosphofructokinase activity(GO:0003872) phosphofructokinase activity(GO:0008443) |
0.1 | 4.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 2.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 0.5 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.1 | 0.4 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 3.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 1.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.6 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.4 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 12.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 6.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.0 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 1.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 2.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 7.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.2 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.1 | 1.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 1.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.5 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.1 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 0.3 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.8 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 1.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 4.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.4 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.2 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 1.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 2.0 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.8 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.1 | 1.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.8 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.7 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.6 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 1.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.7 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 0.3 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 2.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 1.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 9.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 2.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 1.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 1.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 4.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 3.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 3.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 2.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 11.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.6 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.1 | 0.9 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 4.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.4 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.1 | 4.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 2.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.5 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 6.0 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 3.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 2.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.0 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.3 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 1.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 3.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.8 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 15.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.6 | GO:0090484 | drug transporter activity(GO:0090484) |
0.1 | 1.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 1.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 2.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 4.1 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 1.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.2 | GO:0016247 | channel regulator activity(GO:0016247) |
0.1 | 0.2 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.1 | 1.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 1.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.1 | 0.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 2.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.6 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
0.1 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.6 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.1 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.4 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.8 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 2.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 1.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.7 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 4.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 1.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.6 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 1.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.1 | 1.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.8 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.9 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 1.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.2 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 0.3 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 3.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 1.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 7.5 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.2 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.2 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.1 | 0.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 1.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.1 | 0.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.4 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 3.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 12.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 8.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 3.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 1.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 4.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 1.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 1.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.3 | GO:0097617 | annealing activity(GO:0097617) |
0.0 | 1.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.0 | 0.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.5 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 2.6 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 2.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.0 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 1.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.0 | 2.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 1.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 13.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 2.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 1.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.3 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.1 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.0 | 1.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 1.2 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.0 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 2.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 0.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 0.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.3 | GO:0004691 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 1.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.0 | 0.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.5 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.0 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) kinase inhibitor activity(GO:0019210) |
0.0 | 0.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 9.0 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.1 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.2 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.0 | 0.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.5 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.0 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.0 | 0.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.0 | 0.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.9 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.0 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.0 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.0 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 39.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 9.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 10.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 7.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 20.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 9.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 17.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 7.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 17.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 5.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 9.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 16.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 1.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 10.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 5.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 10.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 2.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 10.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 65.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 3.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 8.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 4.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 42.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 5.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 9.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 2.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 4.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 1.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 3.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 4.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 6.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 2.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 8.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 7.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 3.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 4.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 3.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 6.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 5.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 3.0 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 5.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 2.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 3.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 2.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 1.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.3 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 6.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 25.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 2.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 3.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 2.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.6 | 0.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 14.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 11.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 10.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 10.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 8.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 25.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 8.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 3.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 19.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.3 | 2.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 7.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 7.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 3.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 5.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 13.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 11.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 2.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 6.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 4.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 10.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 3.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 6.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 11.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 2.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 3.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 5.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 5.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 5.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 3.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 1.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 7.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 4.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 6.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 5.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 3.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 4.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 2.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 4.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 14.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 11.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 1.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.2 | 7.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 0.4 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 2.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 8.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 11.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 1.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 3.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 5.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 2.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 4.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 13.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 2.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 3.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 3.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 3.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 5.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 2.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.4 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 0.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 2.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 10.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 4.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 5.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 4.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 7.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 3.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 2.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 4.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 4.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 5.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 3.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 3.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 2.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 7.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 2.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 3.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 4.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 4.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 3.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 2.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 18.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 3.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 4.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 3.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 3.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 2.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 2.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 3.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 2.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 3.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 5.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 2.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 5.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 3.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 3.2 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 17.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 4.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 4.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 3.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 6.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.5 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 1.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.0 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 1.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 2.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 1.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.3 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 0.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.4 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |